STIM1 and glioblastoma: Previous experimental studies showed that suppression of STIM1 inhibited cell proliferation of glioblastoma [26], melanoma [22], hepatocellular carcinoma [27], human epidermoid carcinoma [28] and hypopharyngeal carcinoma [29].